Myocardial bridging should be recognized for its malignant potential, including cardiac arrest, particularly in patients without obstructive coronary disease.
MB should not be regarded as uniformly benign. Recognition of its malignant potential-particularly in patients with no obstructive coronary disease-is critical for diagnosis, management, and secondary prevention.
Iyer et al. (Thu,) studied this question.